Meeting
2016 Genitourinary Cancers Symposium
The loss of BAP1 protein expression in the first recurrence site of metastasis to predict prognosis.
Authors
Yuji Miura
Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
Yuji Miura , Naoko Inoshita , Yukinori Ozaki , Yuko Tanabe , Koichi Suyama , Masaomi Ikeda , Toshikazu Okaneya , Toshimi Takano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 599)
DOI
10.1200/jco.2016.34.2_suppl.599
Abstract #
599
Poster Bd #
H18
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Analysis of mutational status in recurrently mutated genes in clear cell renal cell carcinoma and overall survival in patients with metastatic disease at time of nephrectomy.
First Author: Brandon Manley
Poster
2024 ASCO Genitourinary Cancers Symposium
High expression of sialylated cancer-derived IgG and survival in metastatic clear cell renal cell carcinoma.
First Author: Jie Wu
Poster
2015 Genitourinary Cancers Symposium
High concordance of BAP1 and PBRM1 expression in patient-matched primary and metastatic ccRCC tumors.
First Author: Amanda Shreders
Poster
2024 ASCO Genitourinary Cancers Symposium
The immune characteristic analysis of BAP1 mutated clear cell renal cell carcinoma.
First Author: Zilin Wang